Disease- and cell-specific expression of GP73 in human liver disease

American Journal of Gastroenterology

Volumn 99, Issue 6, 2004, Pages 1087-1095

  Iftikhar, Rehan ^b   Kladney, Raleigh D ^b   Havlioglu, Necat ^b   Schmitt Gräff, Annette ^b   Gusmirovic, Ilijas ^b   Solomon, Harvey ^b   Luxon, Bruce A ^b   Bacon, Bruce R ^b   Fimmel, Claus J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GOLGI MEMBRANE PROTEIN; MEMBRANE PROTEIN; PROTEIN GP73; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; DISEASE SEVERITY; GOLGI COMPLEX; HEPATITIS C; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER SINUSOID; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; STELLATE CELL; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING;

ACUTE DISEASE; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELLS, CULTURED; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKERS; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, HUMAN; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MICROSCOPY; MICROSCOPY, CONFOCAL; PROBABILITY; PROGNOSIS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 3142748524     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.30572.x     Document Type: Article

References (26)

1. Shackel NA, Gorrell MD, McCaughan GW. Gene array analysis and the liver. Hepatology 2002;36:1313-25.
2. Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001;75:7059-66.
3. Xu XR, Huang J, Xu ZG, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A 2001;98:15089-94.
4. Lu M, Nakamura RM, Dent ED, et al. Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am J Pathol 2001;159:945-53.
5. Nagayama K, Enomoto N, Miyasaka Y, et al. Overexpression of interferon gamma-inducible protein 10 in the liver of patients with type I autoimmune hepatitis identified by suppression subtractive hybridization. Am J Gastroenterol 2001;96:2211-7.
6. Hsu DK, Dowling CA, Jeng KC, et al. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 1999;81:519-26.
7. Ljubimova JY, Petrovic LM, Wilson SE, et al. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue. J Histochem Cytochem 1997;45:79-87.
8. Satoh S, Nussler AK, Liu ZZ, et al. Proinflammatory cytokines and endotoxin stimulate ICAM-1 gene expression and secretion by normal human hepatocytes. Immunology 1994;82:571-6.
9. Shackel NA, McGuinness PH, Abbott CA, et al. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: Analysis of intrahepatic differential gene expression. Am J Pathol 2002;160:641-54.
10. Martire G, Viola A, Iodice L, et al. Hepatitis C virus structural proteins reside in the endoplasmic reticulum as well as in the intermediate compartment/cis-Golgi complex region of stably transfected cells. Virology 2001;280:176-82.
11. Guasch R, Renau-Piqueras J, Guerri C. Chronic ethanol consumption induces accumulation of proteins in the liver Golgi apparatus and decreases galactosyltransferase activity. Alcohol Clin Exp Res 1992;16:942-8.
12. Kladney RD, Bulla GA, Guo L, et al. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 2000;249:53-65.
13. Kladney RD, Cui X, Bulla GA, et al. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 2002;35:1431-40.
14. Kladney RD, Tollefson AE, Wold WS, et al. Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain. Virology 2002;301:236-46.
15. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 1991;13:372-4.
16. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74.
17. Brunt EM. Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 2002;6:399-420.
18. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977;83:346-56.
19. Zar JH: Biostatistical Analysis. 2nd Ed. Englewood Cliffs: Prentice-Hall, 1984;176-184.
20. Dunn OJ. Multiple contrasts using rank sums. Technometrics 1964;6:241-252.
21. Romano PR, Nikolaeva OV, Steel L, et al. GP73, a resident Golgi membrane protein, appears in sera of patients with viral liver disease and hepatocellular cancer. Hepatology 2003;38:768A.
22. Kladney RD, Ryerse JS, Fimmel CJ. GP73 expression is required for the maintenance of Golgi structure. Hepatology 2002;36:1045A.
23. Yumoto E, Higashi T, Nouso K, et al. Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol 2002;17:285-94.
24. Mizuhara H, Uno M, Seki N, et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 1996;23:1608-15.
25. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002;27:63-8.
26. Willuweit A, Sass G, Schoneberg A, et al. Chronic inflammation and protection from acute hepatitis in transgenic mice expressing TNF in endothelial cells. J Immunol 2001;167:3944-52.